Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Phase II Trial of First-Line Durvalumab and Chemotherapy in Patients With Extra-Pulmonary Small Cell Carcinoma.

JTO clinical and research reports·2026
Same author

Synthesis of a C-2 Functionalized l-Iduronic Acid Derivative as a Candidate Pharmacological Chaperone for MPS II (Hunter Syndrome).

Chemistry, an Asian journal·2026
Same author

Dissecting non-small cell lung cancer (NSCLC) with blood proteomics-from surgical to immunotherapeutic responses.

NPJ precision oncology·2026
Same author

FKBP52 in cancer biology and therapy: molecular mechanisms, signalling networks, and drug targeting of the FKBP protein family.

Biochemical pharmacology·2026
Same author

Steroidal-nitroxide hybrid sustains oxidative stress and enhances cisplatin efficacy in vitro across multiple cancer cell lines.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Defining the tumor microenvironment of non-small cell lung cancer.

Immunology and cell biology·2026

相关实验视频

Updated: Jul 2, 2025

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.5K

针对 hSSB1-INTS3 接口:以计算选驱动的方法来识别潜在的调节器.

Tabassum Khair Barbhuiya1,2, Sam Beard2,3, Esha T Shah2,3

  • 1Centre for Genomics and Personalised Health, and School of Chemistry and Physics, Faculty of Science, Queensland University of Technology, 2 George Street, Brisbane, QLD 4000, Australia.

ACS omega
|February 26, 2024
PubMed
概括

研究人员发现了新型化合物,这些化合物破坏了人类单链DNA结合蛋白1 (hSSB1) 和INTS3.3之间的相互作用. 这一发现提供了一种新的策略,通过抑制DNA修复途径来向癌症.

更多相关视频

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

15.1K
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.5K

相关实验视频

Last Updated: Jul 2, 2025

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.5K
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

15.1K
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.5K

科学领域:

  • 分子生物学分子生物学
  • 结构生物学 结构生物学
  • 癌症研究 癌症研究

背景情况:

  • 人类单链DNA结合蛋白1 (hSSB1) 对于DNA修复至关重要,它与INTS3和C9ORF80.1一起形成SOSS1复合体.
  • 在癌症中hSSB1活性升高表明其作为抗癌治疗点的潜力.
  • 以前的抑制策略集中在hSSB1的DNA结合域上,但取得的成功有限.

研究的目的:

  • 通过在SOSS1复合体内破坏其与INTS3的相互作用来研究hSSB1功能的抑制.
  • 为了确定可以阻碍INTS3-hSSB1蛋白质与蛋白质相互作用 (PPI) 的药物类化合物.

主要方法:

  • 在hSSB1结合界面对INTS3蛋白进行化合物库的分子对接选.
  • 在实验室中使用共免疫沉试验评估PPI破坏.
  • 通过免疫光试验和染色体招募研究评估细胞效应.
  • 分子动力学模拟以评估INTS3热点地点的连接体结合稳定性.

主要成果:

  • 三种化合物在实验室中显示了INTS3-hSSB1相互作用的潜在破坏.
  • 一种化合物显著影响了DNA损伤后hSSB1和INTS3对染色质的招募.
  • 这项研究介绍了首个针对INTS3-hSSB1相互作用的类似药物的化合物.

结论:

  • 破坏INTS3-hSSB1相互作用代表了癌症治疗的新疗法策略.
  • 这些已识别的化合物为进一步的生物物理研究和PPI抑制剂开发提供了基础.
  • 在DNA修复途径中准蛋白质-蛋白质相互作用为抗癌药物发现提供了有前途的途径.